Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
23.56 USD | +3.65% | +4.39% | +30.31% |
Evolution of the average Target Price on Bicycle Therapeutics plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Bicycle Therapeutics plc
HC Wainwright | |
JMP Securities | |
Morgan Stanley | |
B. Riley | |
Oppenheimer | |
Needham & Co. | |
EF Hutton | |
Cowen | |
SVB Securities LLC | |
Barclays | |
Canaccord Genuity | |
Piper Sandler | |
Cantor Fitzgerald | |
SVB Leerink | |
Goldman Sachs |
EPS Revisions
- Stock Market
- Equities
- BCYC Stock
- Consensus Bicycle Therapeutics plc